“Green oncology”: a new paradigm for medical oncology
نویسندگان
چکیده
منابع مشابه
Cardio-oncology: a new medical issue
Due to the increasing number of long-term cancer survivors, the ageing of the population, as well as the increased incidence and prevalence of oncologic and cardiovascular diseases, the number of patients presenting oncologic and cardiologic co-morbidities are increasing. Accordingly, there is a rapidly growing need for a comprehensive and proficient management of patients in whom the two co-mo...
متن کاملMedical Oncology
Objective: Present how the SSG register of bone and soft tissue sarcoma patients has an important role for ensuring quality control and as a basis for research projects. Methods: The SSG Register was initiated in 1986 and more than 5000 patients from sarcoma centers in Finland, Norway and Sweden have been accrued. Patient data was registered at the participating institutions. For in-depth studi...
متن کاملDelayed contrast extravasation MRI: a new paradigm in neuro-oncology.
BACKGROUND Conventional magnetic resonance imaging (MRI) is unable to differentiate tumor/nontumor enhancing tissues. We have applied delayed-contrast MRI for calculating high resolution treatment response assessment maps (TRAMs) clearly differentiating tumor/nontumor tissues in brain tumor patients. METHODS One hundred and fifty patients with primary/metastatic tumors were recruited and scan...
متن کاملWhat Radiation Oncology Wants Medical Oncology to Know
Optimal radiation treatment planning and symptom management for radiotherapy toxicities are keys to patient adherence and good outcomes, according to radiation oncology specialists who described the field at JADPRO Live. J. Nicholas Lukens, MD, of the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, described the basics of radiation oncology, indicating that its target...
متن کاملNeuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology
Pediatric cancers rarely exhibit recurrent mutational events when compared to most adult cancers. This poses a challenge in understanding how cancers initiate, progress, and metastasize in early childhood. Also, due to limited detected driver mutations, it is difficult to benchmark key genes for drug development. In this review, we use neuroblastoma, a pediatric solid tumor of neural crest orig...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2015
ISSN: 0923-7534
DOI: 10.1093/annonc/mdv348.25